Barrett & Company’s Lam Research LRCX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$79.3K Sell
241
-30
-11% -$9.37K 0.02% 253
2026
Q2
$117K Hold
271
– – 0.03% 217
2026
Q1
$57.9K Buy
271
+8
+3% +$1.79K 0.02% 271
2025
Q4
$44.9K Buy
263
+1
+0.4% +$156 0.02% 311
2025
Q3
$35.1K Sell
262
-409
-61% -$43.3K 0.01% 337
2025
Q2
$65.3K Buy
671
+3
+0.4% +$238 0.02% 263
2025
Q1
$48.6K Buy
668
+2
+0.3% +$157 0.02% 274
2024
Q4
$48.1K Sell
666
-2,174
-77% -$165K 0.02% 276
2024
Q3
$232K Hold
2,840
– – 0.1% 128
2024
Q2
$303K Buy
2,840
+500
+21% +$48K 0.14% 105
2024
Q1
$228K Sell
2,340
-2,270
-49% -$200K 0.11% 124
2023
Q4
$361K Buy
4,610
+1,000
+28% +$68.2K 0.2% 89
2023
Q3
$226K Hold
3,610
– – 0.13% 115
2023
Q2
$232K Sell
3,610
-450
-11% -$25.4K 0.13% 115
2023
Q1
$215K Buy
4,060
+3,810
+1,524% +$187K 0.14% 120
2022
Q4
$10.7K Hold
250
– – 0.01% 375
2022
Q3
$10.7K Buy
+250
New +$11.1K 0.01% 375

Other funds holding LRCX

Barrett & Company's LRCX Position: Q3 2026 in Review

Barrett & Company reduced its Lam Research (LRCX) stake by 11% in Q3 2026, selling an estimated $9.37K and leaving 241 shares worth $79.3K. The position accounts for 0.02% of the portfolio, ranked #253.

Barrett & Company first reported a position in LRCX in Q3 2022 and has held it in 17 quarters since. The position peaked at $361K in Q4 2023. 2,969 funds tracked by Wall St. Rank hold LRCX as of Q3 2026.

  • Barrett & Company held 241 shares of Lam Research worth $79.3K as of Q3 2026.
  • Barrett & Company sold 30 Lam Research shares in Q3 2026, an estimated $9.37K.
  • Lam Research made up 0.02% of Barrett & Company's portfolio in Q3 2026, its #253 holding.
  • Barrett & Company first reported a position in Lam Research in Q3 2022 and has held it in 17 quarters since.
  • Barrett & Company's Lam Research position peaked at $361K in Q4 2023.
  • 2,969 funds tracked by Wall St. Rank held Lam Research as of Q3 2026.

Based on Barrett & Company's 13F filing for Q3 2026, filed 22 Oct 2026.